{"product_id":"cy-pharm-business-model-canvas","title":"Challenge \u0026 Young Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChallenge \u0026amp; Young: Business Model Canvas Preview — Download Editable Investor-Ready Template\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore Challenge \u0026amp; Young’s strategic playbook with our concise Business Model Canvas preview—see how value is created, customers are reached, and revenue is captured; download the full Word\/Excel canvas for a detailed, editable breakdown ideal for investors, founders, and consultants seeking actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital Network Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrategic collaborations with major South Korean general hospitals—like Seoul National University Hospital and Asan Medical Center—are essential for clinical validation and adoption; pilot studies in 2024 showed a 28% reduction in medication errors when testing error-reduction tech in high-volume wards. These alliances deliver real-world drug-use protocol testing capacity (typically 200–500 beds each) and align products with operational needs of centers handling 1M+ annual outpatient visits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth Information System Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartnering with Health Information System (HIS) and Electronic Medical Record (EMR) developers embeds our pharmaceutical data into hospital workflows, enabling real-time prescription feeds used by 68% of US hospitals with certified EHRs (2022 ONC). \u003c\/p\u003e\n\u003cp\u003eThese integrations automate cross-checks against patient records, cutting prescribing errors up to 55% in studies, and position our products within a digitized, safety-focused care ecosystem that hospitals invest ~$30k–$120k per bed for IT upgrades. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRaw Material Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMaintaining stable ties with high-quality chemical and active pharmaceutical ingredient (API) suppliers is vital for manufacturing consistency; in 2024, 68% of pharma CPOs reported supplier-related production variance as the top quality risk. Partners must follow Good Manufacturing Practice (GMP) standards to meet FDA and EMA requirements, and signing long-term contracts—covering 2–5 years—cuts supply disruptions and helped firms reduce API price volatility by 12% in 2023.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Government Bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpengaging the ministry of food and drug safety health authorities ensures compliance shortens approval timelines average review days in aligns product specs with south korea evolving healthcare reforms.\u003e\u003cpthese partnerships unlock public procurement korea health spending reached of gdp in access to tenders and reimbursement pathways.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMFDS review ~240 days (2024)\u003c\/li\u003e\n\u003cli\u003ePublic health spend 8.1% of GDP (2023)\u003c\/li\u003e\n\u003cli\u003eProcurement access raises revenue predictability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pengaging\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Cold Chain Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSpecialized logistics and cold chain partners guarantee temperature-controlled transport for pharmaceuticals, covering the supply chain from factory to hospital pharmacy; global cold chain logistics revenue hit about $235 billion in 2024, supporting sub-2°C to -80°C items and cutting spoilage rates by up to 30% for biologics.\u003c\/p\u003e\n\u003cp\u003eEfficient distribution networks ensure timely delivery—median pharma last-mile delivery time fell to 24–48 hours in major markets (2024), preserving efficacy of vaccines and temperature-sensitive meds.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTemperature range: 2°C to -80°C\u003c\/li\u003e\n\u003cli\u003eGlobal cold chain market: $235B (2024)\u003c\/li\u003e\n\u003cli\u003eSpoilage reduction: up to 30% for biologics\u003c\/li\u003e\n\u003cli\u003eMedian last-mile: 24–48 hours (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValidated hospital pilots cut med errors 28%—EHR\/API integrations slash prescribing risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey partnerships: hospital pilots (SNUH, Asan) validate ops—2024 pilots cut medication errors 28% in 200–500-bed wards; HIS\/EMR integrations tap real-time feeds (68% EHR adoption, ONC 2022) and can cut prescribing errors 55%; GMP API suppliers + 2–5y contracts cut price volatility 12% (2023); MFDS review ~240 days (2024); cold chain market $235B (2024), last-mile 24–48h.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2023–2024 data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003eError reduction\u003c\/td\u003e\n\u003ctd\u003e28% (2024 pilots)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHIS\/EMR\u003c\/td\u003e\n\u003ctd\u003eEHR adoption\u003c\/td\u003e\n\u003ctd\u003e68% (ONC 2022)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAPI suppliers\u003c\/td\u003e\n\u003ctd\u003ePrice volatility\u003c\/td\u003e\n\u003ctd\u003e-12% (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulator\u003c\/td\u003e\n\u003ctd\u003eReview time\u003c\/td\u003e\n\u003ctd\u003e~240 days (MFDS 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003eMarket \/ last-mile\u003c\/td\u003e\n\u003ctd\u003e$235B \/ 24–48h (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Challenge \u0026amp; Young Business Model Canvas mapping customer segments, channels, value propositions, revenue streams, resources, activities, partnerships, cost structure, and validation metrics tailored to early-stage ventures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eStreamlines challenge diagnosis with a one-page Young Business Model Canvas that highlights pain points and relief strategies, editable for fast iteration and team collaboration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe core activity is large-scale production of high-quality medicines in GMP-certified plants, with batch release testing (sterility, potency) reducing failure rates to under 1% and ensuring compliance with EMA\/FDA standards.\u003c\/p\u003e\n\u003cp\u003eOperations emphasize line optimization—lean layouts, OEE (overall equipment effectiveness) improvements of 10–15%, and yield gains that cut COGS by ~5% and shorten delivery lead time to providers from 21 to 14 days.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eError Reduction Research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eContinuous R\u0026amp;D targets root causes of prescription and administration errors—WHO estimates med errors affect 1 in 10 patients worldwide—by analyzing workflows and incident data; the company’s specialized packaging and high-contrast labeling cut drug misidentification risk, aiming for a \u0026gt;30% reduction in near-miss events seen in pilot hospitals (2024) and supporting the mission to improve patient safety through better product design.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSystem Integration and Technical Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTeams integrate pharma data into hospital systems for real-time monitoring, syncing drug-use feeds with EHRs and pharmacy systems so 98% of doses are tracked within 60 seconds in pilots (2024 multicenter study). Technical support ensures seamless HL7\/FHIR flows and APIs, reducing medication errors by up to 34% and cutting admin time 18%, giving a data backbone for safer, more efficient care.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistribution and Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eManaging the complex flow from plants to hospitals is a core activity, covering inventory control, demand forecasting, and coordination of cold-chain and urgent transport so hospitals stay stocked with critical meds; global pharma logistics spend hit $120B in 2024 and stockout rates for essential drugs average 8% in low-income regions (WHO, 2024).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInventory turns: target 8–12\/year\u003c\/li\u003e\n\u003cli\u003eForecast accuracy: aim ≥85%\u003c\/li\u003e\n\u003cli\u003eCold-chain ops: 24\/7 tracking\u003c\/li\u003e\n\u003cli\u003eEmergency delivery SLA: ≤6 hours\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Marketing and Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe company runs accredited clinical education for clinicians, showing trial-backed reductions in medication errors (up to 35% in 2024 multicenter audits) and teaching new drug-use protocols that cut administration time by ~12%. Marketing targets safety and efficiency gains, citing $0.8–$1.5M annual cost-savings per 100-bed hospital from fewer adverse drug events.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e35% fewer medication errors (2024 audits)\u003c\/li\u003e\n\u003cli\u003e~12% faster drug administration\u003c\/li\u003e\n\u003cli\u003e$0.8–$1.5M saved\/100-bed hospital annually\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma ops: \u0026lt;1% failures, +10–15% OEE, −5% COGS, 98% dose tracking, \u0026gt;30% fewer med-errors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCore activities: GMP manufacturing with \u0026lt;1% batch failure (EMA\/FDA compliant), ops optimization raising OEE 10–15% and cutting COGS ~5%, R\u0026amp;D + packaging reducing med-errors \u0026gt;30% (2024 pilots), EHR integration tracking 98% doses in 60s (2024), logistics with 8–12 turns\/yr, ≥85% forecast accuracy, 24\/7 cold-chain, ≤6h emergency SLA, training cuts errors 35% and saves $0.8–$1.5M\/100-bed.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBatch failure\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOEE gain\u003c\/td\u003e\n\u003ctd\u003e10–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOGS reduction\u003c\/td\u003e\n\u003ctd\u003e~5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDose tracking\u003c\/td\u003e\n\u003ctd\u003e98% in 60s\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMed-error reduction\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;30% pilots \/ 35% training\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory turns\u003c\/td\u003e\n\u003ctd\u003e8–12\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eForecast accuracy\u003c\/td\u003e\n\u003ctd\u003e≥85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmergency SLA\u003c\/td\u003e\n\u003ctd\u003e≤6 hours\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you see is the actual Challenge \u0026amp; Young Business Model Canvas—not a mockup—and represents the same file you’ll receive after purchase. \u003c\/p\u003e\n\u003cp\u003eUpon completing your order you’ll instantly get this exact deliverable in editable formats, fully formatted and ready to use with all sections included. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749502005625,"sku":"cy-pharm-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/cy-pharm-business-model-canvas.png?v=1772214514","url":"https:\/\/matrixbcg.com\/products\/cy-pharm-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}